Europe Drug Delivery Market is poised to grow at 7.3% from 2017 to 2024

According to Data Bridge Market Research new Market report “Europe Drug Delivery Market, By Route of Administration (Oral (Solid, Liquid, Semi-Solid), Injectable, Topical (Formulations, Transdermal Devices), Pulmonary (MDI, DPI, Nebulizers), Nasal, Ocular, Implantable, Transmucosal), By End-User (Hospitals, Clinics, Home Healthcare, Community Centers, Others), By Distribution Channel (Direct Tenders, Hospital Pharmacies, Pharmacy Stores, Online Pharmacies), By Country (Germany, France, U.K., Spain, Italy, Russia, Netherlands, Switzerland, Turkey, Belgium, Rest of Europe) – Trends and Forecast to 2024”, is projected to reach USD 536.1 billion by 2024, at a CAGR of 7.3% during the forecast period from 2017 to 2024. The new market report contains data for historic years 2014 & 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Report Access: http://databridgemarketresearch.com/reports/europe-drug-delivery-devices-market-trends-and-forecast-to-2024/

Increase in demand for biologics provides opportunities for the drug and the delivery devices manufacturers. Increasing number of regulatory approvals by the European Medicine Agency (EMA) have facilitated companies to introduce biologics used for various treatment purposes. According to the European Medicine Agency, in 2014, the highest number of orphan drugs—17 out 82 recommended drugs—received market authorization approvals in Europe. These orphan drugs are used for the treatment of rare diseases. In 2014, the EMA recommended the marketing authorization for eight new medicines, including Lynparza, Imbruvica, Gazyvaro, and Cyramza. These medicines are used for the treatment of a rare kind of cancer. According to ICON, the EMA approved 40 new medicines in 2014. The EMA increased its budget by 7% for reviewing the performing applications of initial marketing authorization, in 2015.   

Europe Drug Delivery Market - Market Segmentation:

The Europe Drug Delivery market is segmented on the basis of route of administration, end-user, distribution channel, and geography.

On the basis of route of administration the Europe drug delivery market is segmented into oral, injectable, topical, pulmonary, nasal, ocular, implantable and transmucosal. Oral drug is further segmented based on form into solid drug, semi-solid drug and liquid drug. The solid drugs include and are categorized as tablets, capsules, powders and pills. The semi-solid drugs are further segmented into gels, emulsions and elixirs. The liquid drugs are further classified into solutions and syrups.

Based on end users the Europe drug delivery market is segmented into hospitals, over the counter, ambulatory surgery centers/clinics, home care settings, diagnostic centers, and others.

On the basis of distribution channel the market is segmented into Direct Tenders, Hospital Pharmacies, Pharmacy Stores, and Online Pharmacies.

Europe Drug Delivery Market - Geographical Segmentation

Based on geography the Europe Drug Delivery market is segmented into 11 countries, Germany, France, U.K., Spain, Italy, Russia, Netherlands, Switzerland, Turkey, Belgium, and Rest of Europe.

Europe Drug Delivery Market - Competitive Landscape:

The Europe drug delivery market is highly fragmented with various companies operating in local regions. The major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. Some of the examples for these strategies are In November 2016, In November, Pfizer Inc. announced that the European Commission (EC) has approved IBRANCE (palbociclib) for the treatment of women with hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) locally advanced or metastatic breast cancer. The report includes company share data for different countries including Europe, Germany, France, U.K. and Rest of Europe.

Some of the major players operating in the Europe Drug Delivery Market are Bayer AG, Johnson & Johnson, Novartis AG, Pfizer, Inc., F. Hoffmann-La Roche AG, GlaxoSmithKline plc. , Merck & Co., Sanofi, Antares Pharma, 3M, Becton Dickinson and Company, Biolase, Inc., Cima Labs, Inc., West Pharmaceuticals, Antares Pharma, Alkermes, Foamis, Ypsomed, Skyepharma AG, Valeant Pharmaceuticals, DSM Biomedical and Catalent, Inc. among others.

Browse Related Reports:

Global Drug Delivery Devices Market, By Product Type (Oral (Solid, Liquid,Semi-Solid), Injectable (Devices (Conventional, Self-Injectable), Formulations), Topical (Transdermal Devices (Patches, Gels), Formulations), Pulmonary (MDI, DPI, Nebulizers), Nasal, Ocular, Implantable, Transmucosal), By End-User (Hospitals, Clinics, Home Healthcare, Community Healthcare, Others), By Distribution Channel (Hospital Pharmacy, Pharmacy Stores, Direct Tenders, Online Pharmacy), By Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa, Rest of the World) – Trends and Forecast to 2022

http://databridgemarketresearch.com/reports/global-drug-delivery-devices-market/  

Global Topical Drug Delivery Market, By Product Type (Topical Drug Delivery Formulations (Solid, Liquid, Semi Solid), Transdermal Drug Delivery Devices (Transdermal Patches, Transdermal Gels)), By End-User (Hospitals, Clinics, Home Healthcare, Diagnostic Centers, Others), By Distribution Channel (Direct Tenders, Retail), By Geography (North America, Europe, Asia-Pacific, Latin America, Rest of the World) – Trends and Forecast to 2024

http://databridgemarketresearch.com/reports/global-topical-drug-delivery-market-trends-forecast-2024/

Contact:

Data Bridge Market Research

4th Floor, Mega Center,

Magarpatta City, Pune – 411028

Tel: +1-888-387-2818

Email: Sales@databridgemarketresearch.com

Visit Data Bridge Blog@ http://databridgemarketresearch.com/blog/


Browse Related Reports

Global Oral Drug Delivery Market – Industry Trends and Forecast to 2027

Global Nasal Drug Delivery Market – Industry Trends and Forecast to 2027

Global Inflammatory Disease Drug Delivery Market – Industry Trends & Forecast to 2026

Global Buccal Drug Delivery Market - Industry Trends and Forecast to 2026

U.S. Rx Dermatology Topical Drug Delivery Market – Industry Trends and Forecast to 2027

Global Drug Delivery Market – Industry Trends and Forecast to 2027

Asia-Pacific Drug Delivery Market – Industry Trends and Forecast to 2027

Middle East and Africa Drug Delivery Market – Industry Trends and Forecast to 2027

Global Rx Dermatology Topical Drug Delivery Market – Industry Trends and Forecast to 2026

Asia-Pacific Rx Dermatology Topical Drug Delivery Market – Industry Trends and Forecast to 2026

Europe Rx Dermatology Topical Drug Delivery Market – Industry Trends and Forecast to 2026

Middle East - Africa Rx Dermatology Topical Drug Delivery Market – Industry Trends and Forecast to 2026

North America Rx Dermatology Topical Drug Delivery Market – Industry Trends and Forecast to 2026

Global Injectable Drug Delivery Market - Industry Trends and Forecast to 2025

North America Injectable Drug Delivery Market - Industry Trends and Forecast to 2025

Europe Injectable Drug Delivery Market - Industry Trends and Forecast to 2025

Asia-Pacific (APAC) Injectable Drug Delivery Market - Industry Trends and Forecast to 2025

Europe Drug Delivery Market – Industry Trends and Forecast to 2027

Global Topical Drug Delivery Market – Industry Trends - Forecast to 2026

North America Drug Delivery Market – Industry Trends and Forecast to 2027

Europe Topical Drug Delivery Market – Trends and Forecast to 2024

North America Topical Drug Delivery Market – Trends and Forecast to 2024

APAC Topical Drug Delivery Market – Trends and Forecast to 2024

Global Pulmonary Drug Delivery Market- Industry Trends and Forecast to 2024

Global Implantable Drug Delivery Market- Industry Trends and Forecast to 2025

Global Needle-Free Drug Delivery Market – Industry Trends - Forecast to 2026

Global Pulmonary/Respiratory Drug Delivery Market– Industry Trends and Forecast to 2025



Browse Related BLOGS

Global Injectable drug delivery market is poised to reach USD 797.2 billion by 2022

Global Topical Drug Delivery Market is Expected to Reach an Estimated Value of USD 240.76 billion by 2026

North America Drug Delivery Market is poised to grow at 6.4% till 2024

Topical Drug Delivery Market to Grow at a CAGR of 9% in the Forecast Period of 2019 to 2026

Injectable Drug Delivery Market Rising at 12.4% CAGR Due to Surging Prevalence of Chronic Diseases

North America Injectable Drug Delivery Market is Poised to Grow at 11.0% to 2024

Asia-Pacific (APAC) Injectable Drug Delivery Market is Poised to Grow at 12.4% To 2024

Europe Injectable Drug Delivery Market Poised to Grow At 11.9% till 2024

Global Injectable Drug Delivery Market is Expected to Grow by CAGR 11.5% In The Forecast Period 2017 To 2024

North America Drug Delivery Market is Growing at a Significant Rate in the Forecast Period 2017-2024

North America Injectable Drug Delivery Market is Growing at a Significant Rate in the Forecast Period 2017-2024

Global Injectable Drug Delivery Market is Growing at a Significant Rate in the Forecast Period 2018-2025

Global Injectable Drug Delivery Market is Growing at a Significant Rate in the Forecast Period 2018-2025

Nasal Drug Delivery Market to Witness High Demand Due to Rising Respiratory Problems

Increasing Prevalence of Skin Disease or Condition, Rising Aging Population, Growth in Topical Drug Delivery, Increasing Research and Development of New Dermatological Drugs are Expected to Drive the Global Rx Dermatology Topical Drug Delivery Market in the forecast period of 2019-2026

Oral Drug Delivery Market 2019: Size, Share, Scope, Growth Opportunities Analysis By AbbVie, Inc., Amgen, Inc., Catalent Inc, Kemwell Bipharma., Pfizer, Inc., Novartis AG, Biocon, Sanofi, Novo Nordisk A/S. Johnson & Johnson Services, Inc. And Others

U.S. Rx Dermatology Topical Drug Delivery Market is Expected to grow at 4.9% in the Forecast Period of 2020 to 2027

Global Drug Delivery Market is Expected to grow at 8.0% in the Forecast Period of 2020 to 2027